Similarly, the initiators of lectin complement pathway (LCP), including ficolin-1, ficolin-2, ficolin-3, and mannose-binding lectin (MBL), have previously been investigated in SAH patients with inconclusive results that overall seem to suggest an association between plasma levels and severity of brain injury [53,54,55,56]. This evidence concerns the gene FCN2 and injury.